Invasive pneumococcal disease surveillance, 1 April to 30 June 2016

Authors

  • Anna Glynn-Robinson
  • Kate Pennington Vaccine Preventable Diseases Surveillance Section, Office of Health Protection, Australian Government Department of Health, GPO Box 9484, MDP 14, Canberra, ACT 2601
  • Cindy Toms
  • Communicable Diseases Network Australia

DOI:

https://doi.org/10.33321/cdi.2016.40.68

Keywords:

invasive pneumococcal disease, Australia, epidemiology, IPD

Abstract

The number of notified cases of invasive pneumococcal disease (IPD) in the 2nd quarter of 2016 was substantially more than the previous quarter and marginally more than the number of notified cases in the 2nd quarter of 2015. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups, since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011.

Downloads

Download data is not yet available.

Downloads

Published

01/12/16

How to Cite

Glynn-Robinson, Anna, Kate Pennington, Cindy Toms, and Communicable Diseases Network Australia. 2016. “Invasive Pneumococcal Disease Surveillance, 1 April to 30 June 2016”. Communicable Diseases Intelligence 40 (December):564-68. https://doi.org/10.33321/cdi.2016.40.68.

Issue

Vol. 40 (2016)

Section

Quarterly report

Categories

License

Copyright (c) 2016 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 > >>